1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
"Small Business Technology Transfer (STTR) Program" is currently closed and not accepting applications.
Small Business Technology Transfer (STTR) Program is sponsored by National Institute of Mental Health (NIMH), National Institutes of Health (NIH). The NIMH STTR program supports small businesses to develop and commercialize innovative technologies, specifically encouraging collaboration between small businesses and research institutions to stimulate technological innovation in areas such as basic neuroscience research, translational and clinical research, clinical diagnosis and treatment, and dissemination and implementation of evidence-based research on mental disorders.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: Small businesses collaborating with research institutions on innovative technology development in neuroscience and mental health. Confirm the full requirements in the official notice before applying.
The current listing shows up to $250,000 per year for Phase I; up to $450,000 per year for Phase II. Verify award ceilings, matching requirements, and allowable costs in the official notice.
The published deadline was September 5, 2005, which has passed. Check the official notice for any future application windows before investing time in a proposal.
Small Business Technology Transfer (STTR) Program is funded by National Institute of Mental Health (NIMH), National Institutes of Health (NIH). Verify program details on the funder's official page before applying.
Yes — this listing is flagged as national in scope, so applicants across the U.S. may apply, subject to the sponsor's other eligibility criteria.
Applications go through the funder's official portal — the Apply Now link on this page goes there directly.
Past winners and funding trends for this program
BRAIN Initiative: Reagent Resources for Brain Cell Type-Specific Access to Broaden Distribution of Enabling Technologies for Neuroscience (U24 Clinical Trial Not Allowed) is sponsored by National Institute of Mental Health (NIMH), National Institutes of Health (NIH). This funding opportunity supports the establishment of facilities, particularly at minority-serving institutions, to develop and broadly distribute reagent resources for brain cell type-specific access, thereby advancing neuroscience research through innovative neurotechnologies.
School Mental and Behavioral Health: Expanding Access to Evidence-Based Interventions and Services is sponsored by National Institute of Mental Health (NIMH), National Institutes of Health (NIH). This highlighted topic encourages research focused on optimizing and testing school-based mental and behavioral health interventions and service delivery models. It emphasizes research-informed approaches that can be rapidly deployed and sustained in school and afterschool program settings using available resources and personnel. Relevant research includes validating sustainable strategies for operationalizing mental health risk, detecting students at risk, and matching students to appropriate interventions and services, including referring to specialty mental health care when needed.
Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R61/R33 Clinical Trial Required) is sponsored by National Institute of Mental Health (NIMH), National Institutes of Health (NIH). This funding opportunity supports early-stage, clinically grounded research to create and refine new psychosocial interventions and prevention strategies for mental disorders, with a required clinical trial component. It emphasizes an experimental therapeutics approach, focusing on clearly defined intervention targets and demonstrating target engagement in relation to clinical outcomes. The R61 phase provides up to two years for preliminary testing of target engagement, and the R33 phase provides up to three additional years to replicate target engagement and test its association with changes in clinical outcomes.
The Health and Extreme Weather highlighted topic went live September 1, 2026 with eleven awarding institutes and expires May 1, 2028. There is no set-aside, no separate deadline, and no review criteria — which makes the institute-by-institute language the only real signal, and it is not uniform.
Read articleThe NOURISH Autoimmunity Digital Health Challenge runs three phases to August 2028: 10 winners at $20,000, then 5 at $30,000, then 3 at $100,000. It is a prize competition, not a grant — no indirect costs, no cost reimbursement, and a rule that quietly disqualifies the obvious applicant.
Read articlePMHCA (HRSA-26-058) makes $9.79 million available for up to 22 awards of up to $445,000 to build tele-consultation networks that help pediatric primary care providers manage children's behavioral health. The catch buried in the eligibility section: applicants must NOT already hold a PMHCA award — which effectively reserves the new-state lane for the eight unfunded states and territories, plus tribes everywhere. Here's how to read it and what wins.
Read article